search
Back to results

Online Multi-component Psychological Intervention for Depression, Anxiety and Well-being in 7 Countries

Primary Purpose

Anxiety, Depression, Wellbeing

Status
Recruiting
Phase
Not Applicable
Locations
International
Study Type
Interventional
Intervention
Well-being online
Sponsored by
Universidad Internacional de Valencia
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Anxiety

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Age 18 years or older
  • Completion of 100% of the basal evaluation through the form
  • Residence in one of the countries participating in the study
  • Fluency/ proficiency in Spanish (Mexico, Ecuador, Chile, Peru and Spain), Dutch or English (Netherlands) or Portuguese (Brazil), depending on the country.

Exclusion Criteria:

  • Participants with severe symptoms of anxiety and/or depression, or they report a diagnosis of a depression and/or an anxiety disorder.
  • Participants who self-report having another diagnosed psychiatric comorbidity: personality disorder, psychotic disorder, bipolar disorder, Attention-Deficit/Hyperactivity Disorder, or others.
  • Participants taking medication for symptoms of depression and/or anxiety

Sites / Locations

  • Universidade Federal da Bahia
  • Universidad Internacional de Ecuador
  • Universidad Autónoma de Ciudad JuárezRecruiting
  • Tecnólogico de Monterrey
  • Universidad de Guadalajara
  • University of Tilburg
  • Instituto Peruano de Orientación Psicológica
  • Universidad Internacional de Valencia

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Experimental

Experimental

No Intervention

Arm Label

Interactive intervention

non-interactive intervention

Waiting List group

Arm Description

The participants will receive a self-applied intervention composed by 10 sessions following a multi component structure. The participants assigned to this condition will count with interactive resources such as Videos, Online Forum and Exercises embedded on the platform.

Self-administered treatment with 10 sessions will be provided through care manuals in PDF format within the same web platform. Participants in this group will receive a manual within the platform with the same content of the sessions as the experimental group but in PDF format.

The control condition consists of a 30-day waiting list, in which participants will not be able to access the interventions. After the waiting process, they will be given access to either the interactive intervention or the non-interactive intervention.

Outcomes

Primary Outcome Measures

Decrease in the scores of the Center for Epidemiologic Studies Depression (CESD-R) scale
Center for Epidemiologic Studies Depression (CES-D) is a structured self-report scale for evaluation depression symptoms. This scale assesses the number of depression symptoms within 2 weeks. The scale consists 20 items and contains 4-point score responses (0 to 3) as the following; rarely or none of the time (less than 1 day); some of a little of the time (1-2 days); occasionally or moderate amount of time (3-4 days) and most or all of the time (5-7 days). The total possible range of scores is from 0 to 60 where ^16 is the cut-off point for this scale, and higher scores indicate more symptoms of depression. It is expected a statistically significant decrease (P < 0.05) in depression symptoms.
Decrease in the score of the General Anxiety Disorder with 7-items (GAD-7) scale
Is a short scale with items that measure the severity of generalized anxiety disorder symptoms. Responses are based on symptoms perceived during the past week. The questions of this scale are answered in Likert format with 0-3, where the maximum total score is 21. A score between 0 and 4 points indicates that anxiety is not perceived, and a score between 15 and 21 is an indicator of perceived severe anxiety.It is expected a statistically significant decrease (P < 0.05) in anxiety symptoms.
Increase in Mental Psychological Well-being, the Warwick-Edinburgh Mental Well-being Scale (WEMWBS)
It consists of 14 items, including hedonic (i.e. affects, life satisfaction) and eudaimonic (i.e. positive relationships, psychological functioning) items, which together measure mental well-being. Each item is responded in a Likert scale (i.e. 1 = none of the time to 5 = all of the time) and the total score ranges from 14 to 70. The higher the score, the higher the mental well-being

Secondary Outcome Measures

Decrease in The Perceived Stress Scale (PSS-10)
The PSS-10 has ten items with 5 response options (0 = Never, 1 = Almost never, 2 = Sometimes, 3 = Often, 4 = Very often). The interpretation is that the higher the score, the higher the stress level
Decrease in the score of The Pittsburgh Sleep Quality Index
This instrument assesses the quality patterns of sleep. It differentiates the "poor" and "good" sleep by measuring seven areas, where the range score of answers are from 0 to 3, the global sum of this scale can be a value between 0 to 60, and the cutoff point is "5" that indicates a "poor" sleep quality. It is expected a statistically significant increase (P < 0.05) in the Sleep Quality measure.
Decrease in the Action Acceptance Questionnaire II (AAQ-II)
The instrument measures experiential avoidance and psychological inflexibility. It consists of 7 items that are answered using a 7-point Likert scale. The items ask about the unwillingness to experience unwanted emotions and thoughts (e.g., "I am afraid of my feelings", "I worry about not being able to control my worries and feelings") and the inability to be in the present moment.
Increase in The Satisfaction with Life scale
It consists of 5 items in which participants must indicate how much they agree with each question, with a response option in Likert format from 1 (strongly disagree) to 7 (strongly agree). The scores range from 5 to 35, where higher scores indicate greater satisfaction with life.
Decrease in the Perceived Deficits Questionnaire or PDQ-5
The scale asks about problems of functioning in daily life associated with possible cognitive problems, with a 5-point Likert-type response format, ranging from 1- Rarely to 5-Always.
Decrease negative affect in the Positive and Negative Affect Schedule (PANAS)
PANAS comprises two groups consisting of ten terms of either positive or negative affect. Partcipants assess their intensity on a 5-point scale ranging from "not at all" to "extremely", indicating the range of emotions at a given moment or over a period of time, and their chronic or transient nature.
Increase positive affect in the Positive and Negative Affect Schedule (PANAS)
PANAS comprises two groups consisting of ten terms of either positive or negative affect. Partcipants assess their intensity on a 5-point scale ranging from "not at all" to "extremely", indicating the range of emotions at a given moment or over a period of time, and their chronic or transient nature.

Full Information

First Posted
June 22, 2022
Last Updated
January 16, 2023
Sponsor
Universidad Internacional de Valencia
Collaborators
Universidad Autonoma de Ciudad Juarez, University of Guadalajara, Universidad Internacional del Ecuador, Universidad Santo Tomas, Tilburg University
search

1. Study Identification

Unique Protocol Identification Number
NCT05443139
Brief Title
Online Multi-component Psychological Intervention for Depression, Anxiety and Well-being in 7 Countries
Official Title
Well-being Online: Internet-based Self-administered Intervention to Reduce Anxiety and Depression Symptomatology: Randomized Clinical Trial in 7 Countries
Study Type
Interventional

2. Study Status

Record Verification Date
January 2023
Overall Recruitment Status
Recruiting
Study Start Date
December 23, 2022 (Actual)
Primary Completion Date
December 23, 2023 (Anticipated)
Study Completion Date
November 1, 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Universidad Internacional de Valencia
Collaborators
Universidad Autonoma de Ciudad Juarez, University of Guadalajara, Universidad Internacional del Ecuador, Universidad Santo Tomas, Tilburg University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
This study evaluates the effectiveness of an online Multi-component psychological intervention, that is focused on providing self-support to the population of 5 Latin American countries and 2 European Countries. The objectives of the intervention are: 1) To reduce the symptoms of anxiety and depression in the adult population, 2) To increase the levels of subjective well-being.
Detailed Description
Anxiety and depression at clinically significant levels are associated with suicidal thoughts and behaviors. Furthermore, it is associated with the health-disease process in two ways: 1) variables that influence behavior, hindering people's healthy habits and promoting the development of unhealthy behaviors; 2) anxiety and depression affect the psycho physiological activation of people, which affects their immune system. Considering the damage that can occur by not addressing incipient problems of anxiety and depression, it is important to develop interventions with preventive purposes. Thus, the online modality of the intervention presented in this project can benefit a significant number of people in Mexico, Ecuador, Chile, Brazil, Peru, the Netherlands and Spain. The online modality of psychological interventions is a viable treatment alternative, especially for those people who do not have any psychological treatment within their reach. The participants will be measured at pre, middle treatment, post assessment and two follow ups of 3 and 6 months. The self-report measures will include the following Psychometrics: General Anxiety Disorder with 7-items (GAD-7) Center for Epidemiologic Studies Depression Scale" in its revised version (CESD-R). Perceived Stress Scale (PSS-10) Pittsburgh Sleep Quality scale (PSQI) Action Acceptance Questionnaire II (AAQ-II) The Satisfaction with Life scale The Warwick-Edinburgh Mental Well-being Scale (WEMWBS) Perceived Deficits Questionnaire (PDQ-5) The Positive and Negative Affect Schedule (PANAS) Opinion on the treatment. System usability scale. Client Satisfaction Questionnaire (CSQ-8S) The Telehealth Usability Questionnaire (TUQ)

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Anxiety, Depression, Wellbeing, Stress

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
The Well-being Online study will implement a randomized controlled trial at five points for the intervention groups and six evaluation periods for the control group: 1)pretest, 2)middle of the treatment, 3) post-test, 4) follow up at 3 months and 5) follow up at six months. 6) Participants in the control group will be re-assigned to the intervention group after the post-waiting list period. The study will implement a three-arm design (parallel group), comparing: Interactive Intervention Group , Intervention delivered through PDF files. Control group.
Masking
Participant
Masking Description
The patients are not aware that there are another experimental group and a control group. The conditions of the study are only known by the researcher and the Research Ethics Committee of the Universidad Autónoma de Ciudad Juárez.
Allocation
Randomized
Enrollment
200 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Interactive intervention
Arm Type
Experimental
Arm Description
The participants will receive a self-applied intervention composed by 10 sessions following a multi component structure. The participants assigned to this condition will count with interactive resources such as Videos, Online Forum and Exercises embedded on the platform.
Arm Title
non-interactive intervention
Arm Type
Experimental
Arm Description
Self-administered treatment with 10 sessions will be provided through care manuals in PDF format within the same web platform. Participants in this group will receive a manual within the platform with the same content of the sessions as the experimental group but in PDF format.
Arm Title
Waiting List group
Arm Type
No Intervention
Arm Description
The control condition consists of a 30-day waiting list, in which participants will not be able to access the interventions. After the waiting process, they will be given access to either the interactive intervention or the non-interactive intervention.
Intervention Type
Behavioral
Intervention Name(s)
Well-being online
Intervention Description
Multi component Intervention composed 10 sessions following a structure based on Cognitive Behavioral Therapy (CBT), Acceptance and Commitment Therapy (ACT), Positive Psychology (PP), Mindfulness and Behavioral Activation Therapy (BAT).
Primary Outcome Measure Information:
Title
Decrease in the scores of the Center for Epidemiologic Studies Depression (CESD-R) scale
Description
Center for Epidemiologic Studies Depression (CES-D) is a structured self-report scale for evaluation depression symptoms. This scale assesses the number of depression symptoms within 2 weeks. The scale consists 20 items and contains 4-point score responses (0 to 3) as the following; rarely or none of the time (less than 1 day); some of a little of the time (1-2 days); occasionally or moderate amount of time (3-4 days) and most or all of the time (5-7 days). The total possible range of scores is from 0 to 60 where ^16 is the cut-off point for this scale, and higher scores indicate more symptoms of depression. It is expected a statistically significant decrease (P < 0.05) in depression symptoms.
Time Frame
1 to 1.5 months, depending on the development of the patient and the completion of the 10 modules
Title
Decrease in the score of the General Anxiety Disorder with 7-items (GAD-7) scale
Description
Is a short scale with items that measure the severity of generalized anxiety disorder symptoms. Responses are based on symptoms perceived during the past week. The questions of this scale are answered in Likert format with 0-3, where the maximum total score is 21. A score between 0 and 4 points indicates that anxiety is not perceived, and a score between 15 and 21 is an indicator of perceived severe anxiety.It is expected a statistically significant decrease (P < 0.05) in anxiety symptoms.
Time Frame
1 to 1.5 months, depending on the development of the patient and the completion of the 10 modules
Title
Increase in Mental Psychological Well-being, the Warwick-Edinburgh Mental Well-being Scale (WEMWBS)
Description
It consists of 14 items, including hedonic (i.e. affects, life satisfaction) and eudaimonic (i.e. positive relationships, psychological functioning) items, which together measure mental well-being. Each item is responded in a Likert scale (i.e. 1 = none of the time to 5 = all of the time) and the total score ranges from 14 to 70. The higher the score, the higher the mental well-being
Time Frame
Time Frame: 1 to 1.5 months, depending on the development of the patient and the completion of the 10 modules
Secondary Outcome Measure Information:
Title
Decrease in The Perceived Stress Scale (PSS-10)
Description
The PSS-10 has ten items with 5 response options (0 = Never, 1 = Almost never, 2 = Sometimes, 3 = Often, 4 = Very often). The interpretation is that the higher the score, the higher the stress level
Time Frame
1 to 1.5 months, depending on the development of the patient and the completion of the 10 modules
Title
Decrease in the score of The Pittsburgh Sleep Quality Index
Description
This instrument assesses the quality patterns of sleep. It differentiates the "poor" and "good" sleep by measuring seven areas, where the range score of answers are from 0 to 3, the global sum of this scale can be a value between 0 to 60, and the cutoff point is "5" that indicates a "poor" sleep quality. It is expected a statistically significant increase (P < 0.05) in the Sleep Quality measure.
Time Frame
1 to 1.5 months, depending on the development of the patient and the completion of the 10 modules
Title
Decrease in the Action Acceptance Questionnaire II (AAQ-II)
Description
The instrument measures experiential avoidance and psychological inflexibility. It consists of 7 items that are answered using a 7-point Likert scale. The items ask about the unwillingness to experience unwanted emotions and thoughts (e.g., "I am afraid of my feelings", "I worry about not being able to control my worries and feelings") and the inability to be in the present moment.
Time Frame
1 to 1.5 months, depending on the development of the patient and the completion of the 10 modules
Title
Increase in The Satisfaction with Life scale
Description
It consists of 5 items in which participants must indicate how much they agree with each question, with a response option in Likert format from 1 (strongly disagree) to 7 (strongly agree). The scores range from 5 to 35, where higher scores indicate greater satisfaction with life.
Time Frame
1 to 1.5 months, depending on the development of the patient and the completion of the 10 modules
Title
Decrease in the Perceived Deficits Questionnaire or PDQ-5
Description
The scale asks about problems of functioning in daily life associated with possible cognitive problems, with a 5-point Likert-type response format, ranging from 1- Rarely to 5-Always.
Time Frame
1 to 1.5 months, depending on the development of the patient and the completion of the 10 modules
Title
Decrease negative affect in the Positive and Negative Affect Schedule (PANAS)
Description
PANAS comprises two groups consisting of ten terms of either positive or negative affect. Partcipants assess their intensity on a 5-point scale ranging from "not at all" to "extremely", indicating the range of emotions at a given moment or over a period of time, and their chronic or transient nature.
Time Frame
1 to 1.5 months, depending on the development of the patient and the completion of the 10 modules
Title
Increase positive affect in the Positive and Negative Affect Schedule (PANAS)
Description
PANAS comprises two groups consisting of ten terms of either positive or negative affect. Partcipants assess their intensity on a 5-point scale ranging from "not at all" to "extremely", indicating the range of emotions at a given moment or over a period of time, and their chronic or transient nature.
Time Frame
1 to 1.5 months, depending on the development of the patient and the completion of the 10 modules

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Age 18 years or older Completion of 100% of the basal evaluation through the form Residence in one of the countries participating in the study Fluency/ proficiency in Spanish (Mexico, Ecuador, Chile, Peru and Spain), Dutch or English (Netherlands) or Portuguese (Brazil), depending on the country. Exclusion Criteria: Participants with severe symptoms of anxiety and/or depression, or they report a diagnosis of a depression and/or an anxiety disorder. Participants who self-report having another diagnosed psychiatric comorbidity: personality disorder, psychotic disorder, bipolar disorder, Attention-Deficit/Hyperactivity Disorder, or others. Participants taking medication for symptoms of depression and/or anxiety
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Alejandro Domínguez Rodríguez, PhD
Phone
+521 664 471 3277
Email
alejandro.dominguez.r@campusviu.es
First Name & Middle Initial & Last Name or Official Title & Degree
Paulina Erika Herdoiza-Arroyo, PhD
Phone
+593 95 862 5451
Email
pherdoiza@uide.edu.ec
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Mercedes Almela Zamorano, PhD
Organizational Affiliation
Tilburg University
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Reyna Jazmín Martínez Arriaga, PhD
Organizational Affiliation
University of Guadalajara
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
David Villarreal Zegarra, MD
Organizational Affiliation
Instituto Peruano de Orientación Psicológica
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Leivy Patricia González Ramírez, PhD
Organizational Affiliation
Tecnologico de Monterrey
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Adrián Antonio Cisneros Hernández, PhD
Organizational Affiliation
University of Guadalajara
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Marinna Simões Mensorio, PhD
Organizational Affiliation
Independent Researcher
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Rosa Olimpia Castellanos-Vargas, PhD
Organizational Affiliation
Universidad Autónoma de Ciudad Juárez
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Rogéria Lourenço dos Santos, PhD
Organizational Affiliation
Independent Researcher
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Joel Omar González Cantero, PhD
Organizational Affiliation
University of Guadalajara
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Viviana Sylvia Vargas Salinas, PhD
Organizational Affiliation
Independent Researcher
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Joaquín Mateu Mollá, PhD
Organizational Affiliation
Universidad Internacional de Valencia
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Flor Rocío Ramírez Martínez, PhD
Organizational Affiliation
Universidad Autónoma de Ciudad Juárez
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Antonio Carlos Santos da Silva, MD
Organizational Affiliation
Universidad Federal da Bahia
Official's Role
Study Chair
Facility Information:
Facility Name
Universidade Federal da Bahia
City
Ondina
Country
Brazil
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Antonio Carlos Santos da Silva, MD
Email
antoniosilvapsi@gmail.com
Facility Name
Universidad Internacional de Ecuador
City
Quito
Country
Ecuador
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Paulina Erika Herdoiza Arroyo, PhD
Email
pherdoiza@uide.edu.ec
Facility Name
Universidad Autónoma de Ciudad Juárez
City
Juarez
State/Province
Chihuahua
ZIP/Postal Code
32315
Country
Mexico
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Rosa Olimpia Castellanos-Vargas, MD
Phone
+52 33 1358 3137
Email
rosa.castellanos@uacj.mx
First Name & Middle Initial & Last Name & Degree
Flor Rocío Ramírez Martínez, PhD
Email
rocio.ramirez@uacj.mx
Facility Name
Tecnólogico de Monterrey
City
Guadalajara
Country
Mexico
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Leivy Patricia González Ramírez, PhD
Email
leivy@tec.mx
Facility Name
Universidad de Guadalajara
City
Guadalajara
Country
Mexico
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Reyna Jazmin Martínez Arriaga, PhD
Email
reyna.martinez@academicos.udg.mx
First Name & Middle Initial & Last Name & Degree
Adrián Antonio Cisneros Hernández, PhD
Email
adrian.chernandez@academicos.udg.mx
First Name & Middle Initial & Last Name & Degree
Joel Omar González Cantero, PhD
Facility Name
University of Tilburg
City
Tilburg
Country
Netherlands
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Mercedes Almela Zamorano, PhD
Email
M.Almela@tilburguniversity.edu
First Name & Middle Initial & Last Name & Degree
Geert van Boxtel, PhD
Email
G.J.M.vBoxtel@tilburguniversity.edu
Facility Name
Instituto Peruano de Orientación Psicológica
City
Lima
Country
Peru
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
David Villarreal Zegarra, PhD
Email
davidvillarreal@ipops.pe
Facility Name
Universidad Internacional de Valencia
City
Valencia
Country
Spain
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Joaquín Mateu Mollá, PhD
Email
Joaquin.mateu@campusviu.es

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
The information will be available in a private server or in a server of the journal(s) that we will publish the articles that will be the result of this study. The protocol of the study is currently in progress to be published, in this article will be included such study protocol, the informed consent is already shared in the register of clinical trials.
IPD Sharing Time Frame
This data will be available approximately in September 2023 and it will be permanently available. It will be shared in the databases of the journal where the article(s) will be published.
IPD Sharing Access Criteria
Through the servers of the journal(s) where we will publish the articles.
Citations:
Citation
Piqueras Rodríguez, J. A., Martínez González, A. E., Ramos Linares, V., Rivero Burón, R., García López, L. J., & Oblitas Guadalupe, L. A. (2008). Ansiedad, depresión y salud (Anxiety, depression and health). Suma Psicológica, 15, 43-74.
Results Reference
background
PubMed Identifier
28317414
Citation
Podlogar MC, Rogers ML, Stanley IH, Hom MA, Chiurliza B, Joiner TE. Anxiety, depression, and the suicidal spectrum: a latent class analysis of overlapping and distinctive features. Cogn Emot. 2018 Nov;32(7):1464-1477. doi: 10.1080/02699931.2017.1303452. Epub 2017 Mar 20.
Results Reference
background
PubMed Identifier
23459093
Citation
Hofmann SG, Asnaani A, Vonk IJ, Sawyer AT, Fang A. The Efficacy of Cognitive Behavioral Therapy: A Review of Meta-analyses. Cognit Ther Res. 2012 Oct 1;36(5):427-440. doi: 10.1007/s10608-012-9476-1. Epub 2012 Jul 31.
Results Reference
background
PubMed Identifier
25547522
Citation
A-Tjak JG, Davis ML, Morina N, Powers MB, Smits JA, Emmelkamp PM. A meta-analysis of the efficacy of acceptance and commitment therapy for clinically relevant mental and physical health problems. Psychother Psychosom. 2015;84(1):30-6. doi: 10.1159/000365764. Epub 2014 Dec 24.
Results Reference
background
PubMed Identifier
23390882
Citation
Bolier L, Haverman M, Westerhof GJ, Riper H, Smit F, Bohlmeijer E. Positive psychology interventions: a meta-analysis of randomized controlled studies. BMC Public Health. 2013 Feb 8;13:119. doi: 10.1186/1471-2458-13-119.
Results Reference
background
PubMed Identifier
33049431
Citation
Gal E, Stefan S, Cristea IA. The efficacy of mindfulness meditation apps in enhancing users' well-being and mental health related outcomes: a meta-analysis of randomized controlled trials. J Affect Disord. 2021 Jan 15;279:131-142. doi: 10.1016/j.jad.2020.09.134. Epub 2020 Oct 7.
Results Reference
background
PubMed Identifier
24936656
Citation
Ekers D, Webster L, Van Straten A, Cuijpers P, Richards D, Gilbody S. Behavioural activation for depression; an update of meta-analysis of effectiveness and sub group analysis. PLoS One. 2014 Jun 17;9(6):e100100. doi: 10.1371/journal.pone.0100100. eCollection 2014.
Results Reference
background
PubMed Identifier
16717171
Citation
Spitzer RL, Kroenke K, Williams JB, Lowe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006 May 22;166(10):1092-7. doi: 10.1001/archinte.166.10.1092.
Results Reference
result
PubMed Identifier
23469262
Citation
Carleton RN, Thibodeau MA, Teale MJ, Welch PG, Abrams MP, Robinson T, Asmundson GJ. The center for epidemiologic studies depression scale: a review with a theoretical and empirical examination of item content and factor structure. PLoS One. 2013;8(3):e58067. doi: 10.1371/journal.pone.0058067. Epub 2013 Mar 1.
Results Reference
result
PubMed Identifier
6668417
Citation
Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav. 1983 Dec;24(4):385-96. No abstract available.
Results Reference
result
PubMed Identifier
2748771
Citation
Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989 May;28(2):193-213. doi: 10.1016/0165-1781(89)90047-4.
Results Reference
result
PubMed Identifier
22035996
Citation
Bond FW, Hayes SC, Baer RA, Carpenter KM, Guenole N, Orcutt HK, Waltz T, Zettle RD. Preliminary psychometric properties of the Acceptance and Action Questionnaire-II: a revised measure of psychological inflexibility and experiential avoidance. Behav Ther. 2011 Dec;42(4):676-88. doi: 10.1016/j.beth.2011.03.007. Epub 2011 May 25.
Results Reference
result
PubMed Identifier
16367493
Citation
Diener E, Emmons RA, Larsen RJ, Griffin S. The Satisfaction With Life Scale. J Pers Assess. 1985 Feb;49(1):71-5. doi: 10.1207/s15327752jpa4901_13.
Results Reference
result
PubMed Identifier
27551243
Citation
Strober LB, Binder A, Nikelshpur OM, Chiaravalloti N, DeLuca J. The Perceived Deficits Questionnaire: Perception, Deficit, or Distress? Int J MS Care. 2016 Jul-Aug;18(4):183-90. doi: 10.7224/1537-2073.2015-028.
Results Reference
result
PubMed Identifier
33325828
Citation
Sevilla-Gonzalez MDR, Moreno Loaeza L, Lazaro-Carrera LS, Bourguet Ramirez B, Vazquez Rodriguez A, Peralta-Pedrero ML, Almeda-Valdes P. Spanish Version of the System Usability Scale for the Assessment of Electronic Tools: Development and Validation. JMIR Hum Factors. 2020 Dec 16;7(4):e21161. doi: 10.2196/21161.
Results Reference
result
PubMed Identifier
3397865
Citation
Watson D, Clark LA, Tellegen A. Development and validation of brief measures of positive and negative affect: the PANAS scales. J Pers Soc Psychol. 1988 Jun;54(6):1063-70. doi: 10.1037//0022-3514.54.6.1063.
Results Reference
result
PubMed Identifier
18042300
Citation
Tennant R, Hiller L, Fishwick R, Platt S, Joseph S, Weich S, Parkinson J, Secker J, Stewart-Brown S. The Warwick-Edinburgh Mental Well-being Scale (WEMWBS): development and UK validation. Health Qual Life Outcomes. 2007 Nov 27;5:63. doi: 10.1186/1477-7525-5-63.
Results Reference
result

Learn more about this trial

Online Multi-component Psychological Intervention for Depression, Anxiety and Well-being in 7 Countries

We'll reach out to this number within 24 hrs